286 related articles for article (PubMed ID: 28618876)
1. Niosomes for oral delivery of nateglinide: in situ-in vivo correlation.
Sultan AA; El-Gizawy SA; Osman MA; El Maghraby GM
J Liposome Res; 2018 Sep; 28(3):209-217. PubMed ID: 28618876
[TBL] [Abstract][Full Text] [Related]
2. Enhanced oral bioavailability and sustained delivery of glimepiride via niosomal encapsulation: in-vitro characterization and in-vivo evaluation.
Mohsen AM; AbouSamra MM; ElShebiney SA
Drug Dev Ind Pharm; 2017 Aug; 43(8):1254-1264. PubMed ID: 28330377
[TBL] [Abstract][Full Text] [Related]
3. Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs.
Song S; Tian B; Chen F; Zhang W; Pan Y; Zhang Q; Yang X; Pan W
Drug Dev Ind Pharm; 2015 Jan; 41(1):51-62. PubMed ID: 24111828
[TBL] [Abstract][Full Text] [Related]
4. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
[TBL] [Abstract][Full Text] [Related]
5. Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge.
Arzani G; Haeri A; Daeihamed M; Bakhtiari-Kaboutaraki H; Dadashzadeh S
Int J Nanomedicine; 2015; 10():4797-813. PubMed ID: 26251598
[TBL] [Abstract][Full Text] [Related]
6. Niosomes with sorbitan monoester as a carrier for vaginal delivery of insulin: studies in rats.
Ning M; Guo Y; Pan H; Yu H; Gu Z
Drug Deliv; 2005; 12(6):399-407. PubMed ID: 16253956
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
[TBL] [Abstract][Full Text] [Related]
8. Development and biological evaluation of Gymnema sylvestre extract-loaded nonionic surfactant-based niosomes.
Kamble B; Talreja S; Gupta A; Patil D; Pathak D; Moothedath I; Duraiswamy B
Nanomedicine (Lond); 2013 Aug; 8(8):1295-305. PubMed ID: 23259778
[TBL] [Abstract][Full Text] [Related]
9. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits.
Attia IA; El-Gizawy SA; Fouda MA; Donia AM
AAPS PharmSciTech; 2007 Dec; 8(4):E106. PubMed ID: 18181527
[TBL] [Abstract][Full Text] [Related]
10. Menthol augmented niosomes for enhanced intestinal absorption of lopinavir.
Fayed ND; Essa EA; El Maghraby GM
Pharm Dev Technol; 2022 Nov; 27(9):956-964. PubMed ID: 36227222
[TBL] [Abstract][Full Text] [Related]
11. Development of a biocompatible creatinine-based niosomal delivery system for enhanced oral bioavailability of clarithromycin.
Ullah S; Shah MR; Shoaib M; Imran M; Elhissi AM; Ahmad F; Ali I; Shah SW
Drug Deliv; 2016 Nov; 23(9):3480-3491. PubMed ID: 27247018
[TBL] [Abstract][Full Text] [Related]
12. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
13. Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.
Verma P; Prajapati SK; Yadav R; Senyschyn D; Shea PR; Trevaskis NL
Mol Pharm; 2016 Nov; 13(11):3688-3699. PubMed ID: 27632682
[TBL] [Abstract][Full Text] [Related]
14. Metformin hydrochloride and wound healing: from nanoformulation to pharmacological evaluation.
El-Ridy MS; Yehia SA; Elsayed I; Younis MM; Abdel-Rahman RF; El-Gamil MA
J Liposome Res; 2019 Dec; 29(4):343-356. PubMed ID: 30526146
[TBL] [Abstract][Full Text] [Related]
15. Sugar-based novel niosomal nanocarrier system for enhanced oral bioavailability of levofloxacin.
Imran M; Shah MR; Ullah F; Ullah S; Elhissi AM; Nawaz W; Ahmad F; Sadiq A; Ali I
Drug Deliv; 2016 Nov; 23(9):3653-3664. PubMed ID: 27886514
[TBL] [Abstract][Full Text] [Related]
16. Enhanced oral bioavailability of griseofulvin via niosomes.
Jadon PS; Gajbhiye V; Jadon RS; Gajbhiye KR; Ganesh N
AAPS PharmSciTech; 2009; 10(4):1186-92. PubMed ID: 19856107
[TBL] [Abstract][Full Text] [Related]
17. Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan.
Ahad A; Raish M; Al-Jenoobi FI; Al-Mohizea AM
Curr Drug Deliv; 2018 Feb; 15(2):260-266. PubMed ID: 28521674
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of Dissolution and Skin Permeability of Pentazocine by Proniosomes and Niosomal Gel.
Madni A; Rahim MA; Mahmood MA; Jabar A; Rehman M; Shah H; Khan A; Tahir N; Shah A
AAPS PharmSciTech; 2018 May; 19(4):1544-1553. PubMed ID: 29470828
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Surfactant Composition and Surface Charge of Niosomes on the Oral Absorption of Repaglinide as a BCS II Model Drug.
Yaghoobian M; Haeri A; Bolourchian N; Shahhosseni S; Dadashzadeh S
Int J Nanomedicine; 2020; 15():8767-8781. PubMed ID: 33204087
[TBL] [Abstract][Full Text] [Related]
20. Enhanced dissolution and bioavailability of Nateglinide by microenvironmental pH-regulated ternary solid dispersion: in-vitro and in-vivo evaluation.
Wairkar S; Gaud R; Jadhav N
J Pharm Pharmacol; 2017 Sep; 69(9):1099-1109. PubMed ID: 28590055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
